MoneyWorks4Me

Kopran - Quaterly Results

10 Aug 2023 Evaluate
A decrease in the sales to Rs. 658.60 millions was observed for the quarter ended June 2023. The sales stood at Rs. 711.80 millions during the similar quarter previous year.Net Profit for the quarter ended June 2023 dipped to Rs. 1.54  millions from Rs. 38.04 millions  in the corresponding previous quarter.A decline of 23.02 millions was observed in the OP in the quarter ended June 2023 from 66.56 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 658.60 711.80 -7.47 658.60 711.80 -7.47 2730.95 2045.20 33.53
Other Income 14.82 1.73 756.65 14.82 1.73 756.65 160.86 80.27 100.40
PBIDT 23.02 66.56 -65.41 23.02 66.56 -65.41 439.99 234.40 87.71
Interest 9.52 4.95 92.32 9.52 4.95 92.32 26.72 29.53 -9.52
PBDT 13.50 61.61 -78.09 13.50 61.61 -78.09 413.27 204.87 101.72
Depreciation 11.24 10.81 3.98 11.24 10.81 3.98 44.12 43.23 2.06
PBT 2.26 50.80 -95.55 2.26 50.80 -95.55 369.15 161.64 128.38
TAX 0.72 12.76 -94.36 0.72 12.76 -94.36 56.63 44.20 28.12
Deferred Tax -0.55 -1.02 -46.08 -0.55 -1.02 -46.08 -2.09 6.73 -131.05
PAT 1.54 38.04 -95.95 1.54 38.04 -95.95 312.52 117.44 166.11
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.12 482.12 0.00
PBIDTM(%) 3.50 9.35 -62.62 3.50 9.35 -62.62 16.11 11.46 40.57
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..